CRWM
BMY icon

Castle Rock Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

Castle Rock Wealth Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.92M Sell
32,204
-15,665
-33% -$990K 0.36% 69
2026
Q2 		$2.7M Buy
47,869
+1,506
+3% +$86.5K 0.53% 55
2026
Q1 		$2.76M Buy
46,363
+432
+0.9% +$25.2K 0.6% 44
2025
Q4 		$2.58M Buy
45,931
+56
+0.1% +$2.69K 0.56% 50
2025
Q3 		$2.11M Buy
45,875
+1,316
+3% +$61.5K 0.47% 64
2025
Q2 		$2.09M Buy
44,559
+36,576
+458% +$1.8M 0.49% 50
2025
Q1 		$476K Sell
7,983
-669
-8% -$39K 0.13% 147
2024
Q4 		$466K Sell
8,652
-239
-3% -$13.4K 0.11% 149
2024
Q3 		$482K Sell
8,891
-476
-5% -$22.3K 0.12% 157
2024
Q2 		$387K Buy
9,367
+943
+11% +$42.2K 0.1% 169
2024
Q1 		$372K Buy
8,424
+117
+1% +$5.96K 0.1% 167
2023
Q4 		$433K Buy
8,307
+134
+2% +$7.03K 0.13% 154
2023
Q3 		$463K Buy
8,173
+389
+5% +$23.8K 0.16% 142
2023
Q2 		$504K Hold
7,784
– – 0.17% 127
2023
Q1 		$529K Buy
7,784
+1,111
+17% +$78.4K 0.19% 121
2022
Q4 		$487K Buy
6,673
+853
+15% +$64.3K 0.22% 126
2022
Q3 		$405K Buy
5,820
+3
+0.1% +$218 0.2% 128
2022
Q2 		$437K Buy
5,817
+835
+17% +$63.6K 0.22% 122
2022
Q1 		$381K Buy
4,982
+292
+6% +$19.6K 0.18% 155
2021
Q4 		$298K Buy
4,690
+259
+6% +$15.2K 0.12% 188
2021
Q3 		$263K Sell
4,431
-1,052
-19% -$69.3K 0.09% 220
2021
Q2 		$369K Buy
5,483
+58
+1% +$3.78K 0.14% 182
2021
Q1 		$360K Sell
5,425
-7,611
-58% -$474K 0.15% 187
2020
Q4 		$842K Buy
13,036
+2,977
+30% +$183K 0.35% 95
2020
Q3 		$604K Buy
10,059
+2,582
+35% +$155K 0.4% 87
2020
Q2 		$444K Buy
7,477
+829
+12% +$49.6K 0.26% 124
2020
Q1 		$424K Sell
6,648
-7,303
-52% -$446K 0.37% 73
2019
Q4 		$934K Buy
13,951
+3,032
+28% +$174K 0.84% 31
2019
Q3 		$635K Buy
10,919
+49
+0.5% +$2.3K 0.66% 52
2019
Q2 		$488K Buy
+10,870
New +$506K 0.54% 72

Other funds holding BMY

AIM
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return
II
IFM Investors Melbourne, Australia $16B AUM 33.69% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $5.72B AUM 38.26% 1-Year Est. Return
VFM
Viking Fund Management Minot, North Dakota $1.14B AUM 32.65% 1-Year Est. Return
NAM
NorthCrest Asset Manangement Plymouth, Minnesota $4.24B AUM 32.82% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $317M AUM 37.22% 1-Year Est. Return

Castle Rock Wealth Management's BMY Position: Q3 2026 in Review

Castle Rock Wealth Management reduced its Bristol-Myers Squibb (BMY) stake by 33% in Q3 2026, selling an estimated $990K and leaving 32,204 shares worth $1.92M. The position accounts for 0.36% of the portfolio, ranked #69.

Castle Rock Wealth Management first reported a position in BMY in Q2 2019 and has held it in 30 quarters since. The position peaked at $2.76M in Q1 2026. 276 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • Castle Rock Wealth Management held 32,204 shares of Bristol-Myers Squibb worth $1.92M as of Q3 2026.
  • Castle Rock Wealth Management sold 15,665 Bristol-Myers Squibb shares in Q3 2026, an estimated $990K.
  • Bristol-Myers Squibb made up 0.36% of Castle Rock Wealth Management's portfolio in Q3 2026, its #69 holding.
  • Castle Rock Wealth Management first reported a position in Bristol-Myers Squibb in Q2 2019 and has held it in 30 quarters since.
  • Castle Rock Wealth Management's Bristol-Myers Squibb position peaked at $2.76M in Q1 2026.
  • 276 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on Castle Rock Wealth Management's 13F filing for Q3 2026, filed 9 Oct 2026.